Legislation Details

File #: 26-1130    Version: 1 Name:
Type: Agreement Status: Consent
File created: 6/16/2026 In control: Board of Supervisors
On agenda: 6/30/2026 Final action:
Title: HEALTH SERVICES AGENCY / PUBLIC HEALTH
Attachments: 1. cph - Elsevier Amendment #1, 2. cph - #215PA23 ELSEVIER, 3. AATF - Elsevier Amend. #1
Date Ver.Action ByActionResultAction DetailsMeeting DetailsVideo
No records to display.

title

HEALTH SERVICES AGENCY / PUBLIC HEALTH

end

 

Requested Action(s)

recommendation

a) AGREEMENT - Request approval and authorization for the Interim Executive Director to sign Amendment No.1 to the Master Agreement, Tehama County Agreement 215PA23 with Elsevier, Inc. for the purpose of providing access and use of ten (10) licenses for their ClinicalKey product suites. The Amendment will extend the term of the Agreement through 5/31/29, revise the product suites, add Section 7 “Restrictions on Use of Products”, and increase the maximum compensation amount from $46,628.71 to $56,637.76

body

 

Financial Impact:

This Amendment increases the maximum compensation amount by $10,009.05. The funds for this amendment are budgeted in CD 2011. There is no impact to the General Fund.

 

Background Information:

Clinical Pharmacology powered by ClinicalKey is a comprehensive, evidence-based drug reference solution designed to support clinicians in making safe medication decisions and optimizing workflows. It features peer-reviewed content exclusively managed by specialty pharmacists and offers point-of-care access to the latest continuous drug safety updates. The Agreement with Elsevier, Inc. gives the Department the ability to look up current medication recommendations and interactions in order to apply best practice standards to treatment approaches.